Essilor Group, now part of EssilorLuxottica, is recognized as the world's leading company in ophthalmic optics. Founded in 1972, the company is headquartered in France and operates across the Hardware, Health Care, and Medical Devices sectors.
Essilor's mission is to enhance lives by improving sight, a goal supported by an annual investment of over €200 million in research and innovation. This commitment enables Essilor to continuously introduce advanced products to the market. Its well-known brands include Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant®, and Bolon™.
The company boasts a global workforce of around 69,000 employees, with significant manufacturing and R&D capabilities, including 32 plants, 490 prescription labs, 14 distribution centers, and 5 R&D centers. Essilor's last notable investment was an IPO on 01 January 2003.